AMPE
Income statement / Annual
Last year (2023), Ampio Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Ampio Pharmaceuticals, Inc.'s net income was -$8.63 M.
See Ampio Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1.16 M |
$76,787.00 |
Cost of Revenue |
$250,000.00
|
$2.08 M
|
$1.09 M
|
$1.18 M
|
$1.27 M
|
$523,000.00
|
$568,000.00
|
$950,000.00
|
$369,309.00
|
$2.24 M
|
Gross Profit |
-$250,000.00
|
-$2.08 M
|
-$1.09 M
|
-$1.18 M
|
-$1.27 M
|
-$523,000.00
|
-$568,000.00
|
-$950,000.00
|
$793,153.00
|
-$2.16 M
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0.68
|
-28.18
|
Research and Development Expenses |
$2.32 M
|
$8.92 M
|
$11.90 M
|
$9.17 M
|
$12.62 M
|
$6.83 M
|
$10.42 M
|
$10.55 M
|
$18.96 M
|
$26.92 M
|
General & Administrative Expenses |
$7.08 M
|
$11.47 M
|
$8.67 M
|
$6.65 M
|
$5.90 M
|
$4.36 M
|
$5.14 M
|
$6.54 M
|
$15.14 M
|
$12.23 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$7.08 M
|
$11.47 M
|
$8.67 M
|
$6.65 M
|
$5.90 M
|
$4.36 M
|
$5.14 M
|
$6.54 M
|
$15.14 M
|
$12.23 M
|
Other Expenses |
$0.00
|
$1.94 M
|
$0.00
|
$12,000.00
|
$56,000.00
|
$0.00
|
$323,554.00
|
$143,802.00
|
$0.00
|
$0.00
|
Operating Expenses |
$9.27 M
|
$20.38 M
|
$20.57 M
|
$15.83 M
|
$18.58 M
|
$11.18 M
|
$15.56 M
|
$17.08 M
|
$34.10 M
|
$39.15 M
|
Cost And Expenses |
$9.52 M
|
$20.38 M
|
$20.57 M
|
$15.83 M
|
$18.58 M
|
$11.18 M
|
$15.56 M
|
$17.08 M
|
$34.46 M
|
$39.15 M
|
Interest Income |
$348,000.00
|
$220,000.00
|
$4,000.00
|
$12,000.00
|
$77,000.00
|
$5,000.00
|
$3,086.00
|
$23,479.00
|
$59,853.00
|
$22,263.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$77,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$127,000.00
|
$2.08 M
|
$1.09 M
|
$1.18 M
|
$1.27 M
|
$1.28 M
|
$1.21 M
|
$1.21 M
|
$1.14 M
|
$439,098.00
|
EBITDA |
$0.00 |
-$18.30 M |
$0.00 |
$0.00 |
-$17.30 M |
$35.26 M |
-$14.46 M |
-$14.81 M |
-$23.34 M |
$0.00 |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-27.6
|
-503.11
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-28.65
|
-508.83
|
Total Other Income/Expenses Net |
$886,000.00
|
$4.05 M
|
$3.50 M
|
-$60,000.00
|
$4.95 M
|
$45.17 M
|
-$36.22 M
|
-$2.08 M
|
-$412,071.00
|
-$7.60 M
|
Income Before Tax |
-$8.63 M
|
-$16.34 M
|
-$17.08 M
|
-$15.89 M
|
-$13.63 M
|
$33.99 M
|
-$51.89 M
|
-$19.16 M
|
-$33.71 M
|
-$39.05 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-29
|
-508.54
|
Income Tax Expense |
$0.00
|
-$7.87 M
|
-$4.59 M
|
$604,000.00
|
-$4.95 M
|
$45.17 M
|
$36.33 M
|
$1.04 M
|
-$1.29 M
|
-$923,523.00
|
Net Income |
-$8.63 M
|
-$8.47 M
|
-$12.49 M
|
-$16.50 M
|
-$8.68 M
|
$33.99 M
|
-$51.89 M
|
-$19.16 M
|
-$32.01 M
|
-$38.13 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-27.54
|
-496.51
|
EPS |
-10.67 |
-11.24 |
-18.79 |
-28.63 |
-18.32 |
92.1 |
-239.13 |
-107.06 |
-184.7 |
-227.72 |
EPS Diluted |
-10.66 |
-11.24 |
-18.59 |
-27.71 |
-18.32 |
91.9 |
-238.41 |
-106.91 |
-184.7 |
-227.72 |
Weighted Average Shares Out |
$809,000.00
|
$753,615.00
|
$664,330.00
|
$576,155.00
|
$474,026.00
|
$369,000.00
|
$217,000.00
|
$179,000.00
|
$173,306.00
|
$167,421.00
|
Weighted Average Shares Out Diluted |
$810,113.00
|
$753,619.00
|
$671,493.00
|
$595,407.00
|
$474,026.00
|
$369,805.00
|
$217,658.00
|
$179,244.00
|
$173,306.00
|
$167,421.00
|
Link |
|
|
|
|
|
|
|
|
|
|